Age: 55.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Abdominal pain upper, Back pain, Bedridden, Dyspnoea, Feeling abnormal
Clinical narrative: Infection; Fibromyalgia; Neck pain; Back pain; Kidney disorder; Pain; Difficulty breathing; Pain stomach; Weird feeling; Headache; Rheumatoid arthritis; bedridden; Pneumonia; This spontaneous case was reported by a physician and describes the occurrence of PNEUMONIA (Pneumonia), RHEUMATOID ARTHRITIS (Rheumatoid arthritis), BEDRIDDEN (bedridden), INFECTION (Infection), FIBROMYALGIA (Fibromyalgia), NECK PAIN (Neck pain), BACK PAIN (Back pain), RENAL DISORDER (Kidney disorder), PAIN (Pain), DYSPNOEA (Difficulty breathing), ABDOMINAL PAIN UPPER (Pain stomach), FEELING ABNORMAL (Weird feeling) and HEADACHE (Headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and UPADACITINIB (Oral) at an unspecified dose. On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criteria hospitalization prolonged and medically significant), RHEUMATOID ARTHRITIS (Rheumatoid arthritis) (seriousness criteria hospitalization and medically significant), BEDRIDDEN (bedridden) (seriousness criterion hospitalization prolonged), INFECTION (Infection) (seriousness criterion hospitalization), FIBROMYALGIA (Fibromyalgia) (seriousness criterion hospitalization), NECK PAIN (Neck pain) (seriousness criterion hospitalization), BACK PAIN (Back pain) (seriousness criterion hospitalization), RENAL DISORDER (Kidney disorder) (seriousness criterion hospitalization), PAIN (Pain) (seriousness criterion hospitalization), DYSPNOEA (Difficulty breathing) (seriousness criterion hospitalization), ABDOMINAL PAIN UPPER (Pain stomach) (seriousness criterion hospitalization), FEELING ABNORMAL (Weird feeling) (seriousness criterion hospitalization) and HEADACHE (Headache) (seriousness criterion hospitalization). At the time of the report, PNEUMONIA (Pneumonia), RHEUMATOID ARTHRITIS (Rheumatoid arthritis), BEDRIDDEN (bedridden), INFECTION (Infection), FIBROMYALGIA (Fibromyalgia), NECK PAIN (Neck pain), BACK PAIN (Back pain), RENAL DISORDER (Kidney disorder), PAIN (Pain), DYSPNOEA (Difficulty breathing), ABDOMINAL PAIN UPPER (Pain stomach), FEELING ABNORMAL (Weird feeling) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  Company comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.